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Transcriptomic and metabolomic profiling of
chicken adipose tissue in response to insulin
neutralization and fasting
Bo Ji1, Ben Ernest1, Jessica R Gooding2, Suchita Das1, Arnold M Saxton1, Jean Simon3, Joelle Dupont4,
Sonia Métayer-Coustard3, Shawn R Campagna2 and Brynn H Voy1,5*
Abstract
Background: Domestic broiler chickens rapidly accumulate adipose tissue due to intensive genetic selection for
rapid growth and are naturally hyperglycemic and insulin resistant, making them an attractive addition to the suite
of rodent models used for studies of obesity and type 2 diabetes in humans. Furthermore, chicken adipose tissue is
considered as poorly sensitive to insulin and lipolysis is under glucagon control. Excessive fat accumulation is also
an economic and environmental concern for the broiler industry due to the loss of feed efficiency and excessive
nitrogen wasting, as well as a negative trait for consumers who are increasingly conscious of dietary fat intake.
Understanding the control of avian adipose tissue metabolism would both enhance the utility of chicken as a
model organism for human obesity and insulin resistance and highlight new approaches to reduce fat deposition
in commercial chickens.
Results: We combined transcriptomics and metabolomics to characterize the response of chicken adipose tissue to
two energy manipulations, fasting and insulin deprivation in the fed state. Sixteen to 17 day-old commercial broiler
chickens (ISA915) were fed ad libitum, fasted for five hours, or fed but deprived of insulin by injections of
anti-insulin serum. Pair-wise contrasts of expression data identified a total of 2016 genes that were differentially
expressed after correction for multiple testing, with the vast majority of differences due to fasting (1780 genes).
Gene Ontology and KEGG pathway analyses indicated that a short term fast impacted expression of genes in a
broad selection of pathways related to metabolism, signaling and adipogenesis. The effects of insulin neutralization
largely overlapped with the response to fasting, but with more modest effects on adipose tissue metabolism. Tissue
metabolomics indicated unique effects of insulin on amino acid metabolism.
Conclusions: Collectively, these data provide a foundation for further study into the molecular basis for adipose
expansion in commercial poultry and identify potential pathways through which fat accretion may be attenuated in
the future through genetic selection or management practices. They also highlight chicken as a useful model
organism in which to study the dynamic relationship between food intake, metabolism, and adipose tissue biology.
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Background
The domestic chicken provides a widespread and relatively
inexpensive source of dietary protein for humans. In
addition to its role as a food animal, the chicken has a long
history as a valuable model research organism [1]. These
dual considerations led to the selection of chicken as the
first agricultural animal model to be sequenced at the gen-
ome level [2]. While chickens have been used heavily for
studies of developmental biology and immunology, a num-
ber of traits make them a viable model for studies of adi-
pose biology, obesity and insulin resistance. Commercial
broiler chickens, in particular, rapidly accumulate excess
adipose tissue as a result of genetic selection for growth
and are considered “obese” relative to leaner egg-laying or
wild strains of chickens(rev. in [3]). Chickens mimic the
early stage of type 2 diabetes in humans, exhibiting both
hyperglycemia (up to 200 mg/dL in the fasting state) and
resistance to exogenous insulin [4,5]. Like humans, but un-
like rodents or pigs, chickens rely on liver rather than adi-
pose tissue for the majority of de novo lipid synthesis [6-8].
Most metabolic genes are conserved with humans, and a
number of the quantitative trait loci (QTLs) that have been
linked to fatness in chickens contain genes implicated in
human susceptibility to obesity or diabetes [9]. Chickens
also represent a model for studying mechanisms of adipo-
cyte hyperplasia during development, a process that may
exacerbate adult obesity. During at least the first several
weeks after hatch, chicken adipose tissue expands more
through adipocyte hyperplasia than hypertrophy, and an
early increase in adipocyte number is a common feature of
some lines genetically selected for excess adiposity [10,11].
Finally, the egg presents opportunities to directly manipu-
late the developmental milieu and study the consequences
on adipose metabolism via in ovo injection.
Relatively little is known about regulation of adipose tis-
sue deposition and metabolism in chicken. Because of its
relative importance in lipogenesis, most studies have fo-
cused on the role of liver in adipose expansion. Several
genetic lines of fat and lean chickens have been developed
through phenotypic selection, most of which have both ele-
vated plasma levels of very low density lipoprotein (VLDL)
and lower levels of plasma glucose, reflecting the import-
ance of hepatic lipogenesis and glucose consumption in fat
accretion. Reciprocally, phenotypic selection for low
plasma glucose simultaneously selects for fatness [12]. Both
chicken and mammalian adipocytes develop through a
sequence of molecular triggers including activation of
CCAAT-enhancer-binding protein alpha (CEBPα) and per-
oxisome proliferator-activated receptor gamma (PPARγ)
[13]. A clear point of divergence, however, is their respon-
siveness to insulin. Unlike in mammals, insulin has min-
imal effect on glucose uptake in chicken adipose tissue
[14]. In fact, an avian homolog of the insulin-sensitive glu-
cose transporter GLUT4 has not been identified in the
current chicken genome database. Insulin does, however,
stimulate uptake of acetate, which is the preferred substrate
for de novo lipogenesis in chicken adipocytes, although the
magnitude of the effect is relatively modest [15]. Insulin
signaling appears to proceed through tissue specific cas-
cades in chicken metabolic tissues. In liver, insulin elicits a
signaling cascade that parallels the response in mammals,
including tyrosine phosphorylation of insulin receptor
β-subunit (IRβ), insulin receptor substrate-1 (IRS-1) and
Src homology 2 domain-containing substrate (Shc) and ac-
tivation of phosphatidylinositol 3-kinase (PI3K) [16,17].
The situation in skeletal muscle is more complex. Tyrosine
phosphorylation of IRβ and IRS-1 and PI3K activity are not
regulated by insulin, whereas events downstream of PI3K
(e.g. Akt and P70S6K activation) are accordingly sensitive
[18]. We recently reported that insulin also does not elicit a
classical IRβ initiated cascade in chicken adipose tissue, in-
cluding the downstream steps of Akt and P70S6K activa-
tion [19]. Insulin also does not inhibit lipolysis in chicken
adipose tissue; glucagon, is the primary lipolytic hormone
(rev. in [20]).
In the present study we simultaneously characterized
the effects of a short term (5 hours) fast or neutralization
of insulin action (5 hours) on adipose tissue of young
(16–17 day-old), fed commercial broiler chickens. The
goals of this study were two-fold. First, we sought to iden-
tify pathways activated by feed restriction, reasoning that
they may highlight potential strategies for control of fatness
through either genetic selection or improved management
practices. Simultaneously, we sought to understand the
contribution of insulin, if any, into chicken adipose physi-
ology. No experimental model of diabetes exist in chicken:
total pancreatectomies are not achievable, and alloxan and
streptozotocin are inefficient at destroying pancreatic
chicken beta-cells (rev. in [5]). The two treatments were
compared to distinguish potential insulin-specific changes
from those that could be mimicked by fasting through
changes in nutrient availability. Both treatments were
shown previously to elicit significant alterations in several
plasma metabolic and endocrine parameters [18]; in the
studies reported herein, samples of abdominal adipose tis-
sue were issued from the same experiment. Tissue metabo-
lomics was combined with microarrays to bridge the gap
between gene expression, metabolic and physiological
responses, and to identify the composite effects of both
fasting and insulin deprivation on chicken adipose tissue.
Results
Expression levels of a total of 2016 genes were signifi-
cantly altered by fasting and/or insulin neutralization
when compared to fed controls based on an FDR
adjusted p-value < 0.05 (Additional file 1; Figure 1A).
Sixty-nine percent of these genes showed a fold-change ≥
|1.5| (Figure 1B). The majority of changes in expression
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were attributable to fasting, with 917 up-regulated and
863 down-regulated genes in fasted vs. fed adipose tis-
sue. Insulin neutralization altered expression of 92
genes, 72 of which were also differentially expressed with
fasting (Figure 1A). All genes that were affected by both
treatments changed in the same direction (i.e., up- or
down-regulated in both groups). Real-time RT-PCR was
employed to validate differential expression based on the
microarray data. Eleven genes were selected based on
fold-change or biological functions of interest (Table 1).
Differential expression under fasting versus fed conditions
was validated for all genes except pre-B-cell leukemia
homeobox 3 (PBX3). Ten of the eleven genes were also
differentially expressed in insulin neutralized compared to
fed birds based on QPCR.
Genes that were differentially expressed in at least one
pairwise comparison were clustered to visualize the si-
milarities between groups and to determine if insulin-
neutralized expression profiles were more similar to fasted
or to fed status. As shown in Figure 2A, samples within
each of the three experimental groups clustered together.
The dendrogram also showed that the fasting group was
distant from fed and insulin-neutralized groups, which
were closer to each other. To further visualize relationships
between treatments with regard to gene expression,
distinct clusters of genes were extracted and submitted to
gene set enrichment analysis to identify GO terms and
pathways that were significantly overrepresented among
genes contained in these clusters. Seven clusters repre-
sented four general patterns of similarities between treat-
ments (Figure 2B). Clusters 1, 3 and 4 consisted of genes
with higher expression in fasting compared to both insulin-
neutralized and fed conditions, with insulin-neutralized
intermediate between fasted and fed. This set of genes was
significantly enriched in GO terms related to protein and
lipid catabolism and to cell signaling, including regulation
of the stress-sensitive NFκB cascade (Table 2). These three
clusters were also enriched in members of the KEGG path-
ways ubiquitin mediated proteolysis, sphingolipid meta-
bolism, PPAR signaling, fatty acid metabolism and the
peroxisome. The rate-limiting genes for fatty acid oxidation
(ACOX1 and CPT1A), along with fatty acid binding pro-
teins 5 and 6, are contained in these three clusters. Clusters
5 and 7 also contained genes with higher levels in fasted vs.
the other two groups, but with comparable expression
levels between insulin-neutralized and fed, and thus no
clear effect of insulin loss. These two clusters were signifi-
cantly enriched in pathways related to signaling and metab-
olism, including enzyme linked receptor protein signaling
pathway (p=0.0097) and in the KEGG pathways for glycer-
olipid metabolism and PPAR. Genes responsible for the lat-
ter enrichment include PPARΔ, which was recently shown
to increase total oxidative metabolism in white adipose tis-
sue [21]. Clusters 2 and 6 contained genes expressed at
lowest levels in fasted chickens. Genes in cluster 2 were
expressed at intermediate levels in the insulin-neutralized
group relative to fed and fasted. This set of genes was sig-
nificantly enriched in GO annotations related to monosac-
charide catabolic process and glucose metabolism, and in
genes comprising the KEGG pathways for carbohydrate
metabolism, TCA cycle and glycolysis (Table 2). Finally,
Figure 1 Venn diagram of overlapping and unique effects of
fasting and insulin neutralization on gene expression. (A) A
total of 2016 unique genes were differentially expressed (FDR
adjusted p-value <0.05) between one or more pairwise treatment
comparisons; (B) A total of 1401 genes with absolute fold change
≥1.5 among the differentially expressed genes.
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cluster 6 consisted of genes that were also lowest in fasting
but showed no clear effect of insulin loss, with similar ex-
pression in fed and insulin-neutralized groups. This set of
genes was significantly enriched for the KEGG pathways
steroid biosynthesis (p=0.0043), glyoxylate and dicarboxy-
late metabolism (P=0.012) and pyruvate metabolism
(P=0.033), along with a number of genes involved in lipid
biosynthesis, which was the highest scoring GO category
(p=0.6). Cluster 8 was a distinct, small cluster with variable
expression within group and no significant GO or KEGG
annotations.
Global biological responses to fasting and to insulin
neutralization were further characterized using KEGG
pathway matching, based on genes with statistically signifi-
cant differential expression (FDR<0.05) and absolute fold-
change ≥1.5. Genes altered exclusively by fasting repre-
sented a wide range of cellular pathways, indicating signifi-
cant effects of even a five hour fast on adipose function
and metabolism in chicken. Fasting exerted significant
effects on pathways related to carbohydrate, amino acid
and lipid metabolism and synthesis. Within the categories
related to lipid metabolism, fasting up-regulated expres-
sion of genes involved in fatty acid oxidation (e.g., acyl-
CoA oxidase 1 (ACOX1), acetyl-CoA carboxylase beta
(ACACB), carnitine palmitoyltransferase 1A (CPT1A))
and down-regulated expression of genes that control fatty
acid, cholesterol and triacylglycerol synthesis (e.g., 1-acyl-
glycerol-3-phosphate O-acyltransferase 9 (AGPAT9), ATP
citrate lyase (ACLY), farnesyl diphosphate synthase (FDPS),
acetyl-Coenzyme A carboxylase alpha (ACACA) and
acetoacetyl-CoA synthetase (AACS)). Fasting also up-
regulated expression of many genes involved in proteolysis
and amino acid degradation. In addition to pathways high-
lighted by KEGG analysis, fasting down-regulated a number
of genes (e.g., TGFβ, BMP) that mediate mesenchymal stem
cell (MSC) commitment, an early step in the formation of
new adipocytes (Additional file 1). Finally, a number of
phosphodiesterases were up-regulated with fasting, pre-
sumably in response to the increased plasma glucagon [18]
and subsequent elevations in cyclic adenosine monopho-
sphate (cAMP; Additional file 1). Collectively, these cat-
egories indicate that chicken adipose tissue responds to a
relatively short duration (five hour) fast with sweeping
changes in gene expression that suppress synthesis and
storage of lipids and other macromolecules and up-regulate
mobilization and metabolism of fatty acids and proteins.
Loss of insulin action also resulted in significant effects
on adipose gene expression, the majority of which over-
lapped with the response to fasting (Table 3; Additional
file 2). Several genes central to energy metabolism were
affected. Diacylglycerol O-acyltransferase homolog 2
(DGAT2), which catalyzes the final and only committed
step in triacylglycerol synthesis, was down-regulated
(10.5-and 6.1-fold, respectively, fasted and insulin neutra-
lized) in both treatment groups relative to the fed group.
Conversely, acyl-Coenzyme A binding domain containing
5 (ACBD5) and pyruvate dehydrogenase kinase 4 (PDK4)
were significantly up-regulated in both treatments relative
to fed controls. ACBD5 is one of a family of long chain
fatty acyl CoA trafficking proteins that play roles in both
triglyceride synthesis and beta-oxidation [22]. PDK4,
which was up-regulated vs. fed by~17-fold with fasting
and 6-fold with insulin neutralization, acts as a fuel switch
by phosphorylating and inactivating pyruvate dehydrogen-
ase, shifting metabolism from glycolysis to fatty acid oxi-
dation [23]. Fasting and insulin neutralization also up-
regulated expression of the type I angiotensin II receptor
(AGTR1). Angiotensin II alters adipocyte lipid metabolism
and insulin signaling [24-26], and increased AGTR1 ex-
pression in adipose tissue is associated with enhanced
Table 1 Fold change verification of gene expression by RT-PCR
Gene
symbol













FBXO8 F-box protein 8 4.16*** 2.09** −1.99*** 2.59*** 2.76*** 1.06
DUSP5 Dual specificity phosphatase 5 9.43*** 1.05 −8.98*** 8.13*** 1.69*** −4.82***
BNIP3 BCL2/adenovirus E1B 19 kDa interacting protein 3 2.98*** 1.53 −1.95** 3.45*** 2.26*** −1.52*
PBX3 Pre-B-cell leukemia homeobox 3 −1.62*** 1.07 1.75*** −1.22 1.83*** 2.22***
IL10RB Interleukin 10 receptor, beta 1.74*** 1.02 −1.71** 1.76*** 1.42* −1.24
EGR1 Early growth response 1 2.43* −1.58 −3.86** 2.58*** −1.36 −3.52***
NAB1 NGFI-A binding protein 1 (EGR1 binding protein 1) 2.43*** 1.06 −2.29*** 1.67** 1.52** −1.10
PDK4 Pyruvate dehydrogenase kinase, isozyme 4 17.28*** 7.06** −2.45** 18.33*** 4.01*** −4.57***
CTSL2 Cathepsin L2 2.09*** 1.55* −1.35* 2.96*** 2.053*** −1.44
AGTR1 Angiotensin II receptor, type 1 4.15 *** 2.05* −2.02** 3.52** 1.72* −2.05*
SESN1 Sestrin 1 1.86** 1.125 −1.65 1.58* 1.47* 1.07
FDR p-value: * p < 0.05, ** p < 0.005, *** p < 0.0005.
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Figure 2 (See legend on next page.)
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Figure 2 Cluster analysis of differentially expressed genes. The 2016 genes differentially expressed in one or both treatment groups vs. fed
controls were subjected to hierarchical clustering to visualize similarities and differences between treatment groups. (A). Hierarchical cluster
analysis of the 2016 genes (FDR adjusted p-value <0.05) that were differentially expressed between insulin-neutralized vs. fed and/or fasted vs. fed
states. (B) Seven clusters (numbers) representing the most distinct effects of treatment were selected to further analyze expression profiles across
treatments. Sample ID number on the X-axis corresponds to treatment group: sample 1–5, fasted; 6–10, insulin neutralized; 11–15,fed control.
Y-axis represents relative gene expression value.
Table 2 Gene ontology (GO) and KEGG annotation for representative clusters of differentially expressed genes
Cluster Annotation GO term (Biological Process, level 6 or 7) or KEGG pathway name FDR p-value
1, 3 and 4 (731 genes) GO Positive regulation of protein metabolic process 6.0 E-3
Negative regulation of cellular macromolecule biosynthetic process 7.3 E-3
Triglyceride metabolic process 1.0 E-2
Negative regulation of gene expression 1.0 E-2
Proteolysis involved in cellular protein catabolic process 1.0 E-2
Negative regulation of kinase activity 1.5 E-2
Regulation of transcription, DNA-dependent 2.1 E-2
Protein phosphorylation 3.3 E-2
Antigen receptor-mediated signaling pathway 3.3 E-2
Regulation of phosphate metabolic process 3.4 E-2
Regulation of kinase activity 3.4 E-2
Regulation of I-kappaB kinase/NF-kappaB cascade 3.5 E-2
KEGG Ubiquitin mediated proteolysis 1.0 E-2
Sphingolipid metabolism 1.8 E-2
PPAR signaling pathway 2.4 E-2
Fatty acid metabolism 4.6 E-2
Peroxisome 5.0 E-2
2 (557 genes) GO Monosaccharide catabolic process 2.5 E-2
DNA dependent DNA replication 3.6 E-3
Hexose metabolic process 1.1 E-2
Glucose metabolic process 1.4 E-2
Regulation of cell shape 1.5 E-2
DNA replication 1.5 E-2
Nucleoside triphosphate metabolic 2.3 E-2
KEGG Glycolysis / Gluconeogenesis 4.9 E-4
Citrate cycle (TCA cycle) 8.9 E-4
6 (402 genes) KEGG Steroid biosynthesis 4.4 E-3
Glyoxylate and dicarboxylate metabolism 1.2 E-2
Pyruvate metabolism 3.3 E-2
5 and 7 (250 genes) GO Enzyme linked receptor protein signaling pathway 9.7 E-3
Regulation of cellular protein metabolic process 3.1 E-2
Negative regulation of macromolecule metabolic process 3.5 E-2
Transmembrane receptor protein serine/threonine kinase signaling pathway 3.6 E-2
Negative regulation of protein metabolic process 3.7 E-2
Positive regulation of cellular metabolic process 4.4 E-2
KEGG PPAR signaling pathway 1.0 E-4
Glycerolipid metabolism 1.8 E-2
MAPK signaling pathway 4.6 E-2
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insulin sensitivity [27]. Finally, a number of genes regu-
lated by both fasting and insulin neutralization function in
general processes related to protein synthesis.
A total of thirteen genes (four up-regulated and nine
down-regulated) were differentially expressed only with
insulin neutralization (Table 4). The most interesting of
these responses were upregulation of GCG, which encodes
preproglucagon (fold change=2.91), in parallel with down-
regulation of the glucagon receptor (LOC425670, fold
change=−2.77). Other genes uniquely affected by insulin
have less clear relevance to adipose biology according to
current knowledge.
Tissue metabolomic analysis was used to identify the
metabolic intermediates that were altered by fasting and
insulin neutralization. A total of 92 metabolites were
detected based on signal-to-noise ratios (Additional file 3).
It is worth noting that glucose-6-phosphate content was
similar in fasted or “diabetic” vs. fed status, despite a large
range of plasma glucose levels (232–747 mg/100 ml). A
total of 12 metabolites were significantly different between
Table 3 Shared effects of fasting and insulin-neutralization on differential gene expression
Gene
symbol





PDK4 pyruvate dehydrogenase kinase, isozyme 4 7.06 17.28
AOX1 aldehyde oxidase 1 2.94 6.66
PLEKHH2 pleckstrin homology domain containing, family H (with MyTH4 domain) member 2 2.41 2.77
FBXO8 F-box protein 8 2.09 4.15
AGTR1 angiotensin II receptor, type 1 2.04 4.15
PCMTD1 protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 1.99 2.25
PSME4 proteasome (prosome, macropain) activator subunit 4 1.97 3.86
ICA1 islet cell autoantigen 1, 69 kDa 1.85 2.8
IP6K2 inositol hexakisphosphate kinase 2 1.77 2.75
UHRF2 ubiquitin-like, containing PHD and RING finger domains, 2 1.72 1.89
ACBD5 acyl-Coenzyme A binding domain containing 5 1.72 2.51
LOC417776 similar to hypothetical protein 1.62 1.84
CTSL2 cathepsin L2 1.54 2.09
ZNF217 zinc finger protein 217 1.54 2.6
IFNAR1 Interferon (alpha, beta and omega) receptor 1 1.52 3.47
Down-regulated genes
DGAT2 diacylglycerol O-acyltransferase homolog 2 (mouse) 6.1 10.5
EEPD1 endonuclease/exonuclease/phosphatase family domain containing 1 2.4 2.17
ANKRD9 ankyrin repeat domain 9 2.19 1.98
DLST dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex 1.95 1.76
PTP4A3 protein tyrosine phosphatase type IVA, member 3 1.8 2.3
HSPA5 heat shock 70 kDa protein 5 (glucose-regulated protein, 78 kDa) 1.76 1.74
NOLA2 nucleolar protein family A, member 2 (H/ACA small nucleolar RNPs) 1.73 1.57
MST1R macrophage stimulating 1 receptor (c-met-related tyrosine kinase) 1.71 2.2
GRAMD2 GRAM domain containing 2 1.69 2.37
DHDDS dehydrodolichyl diphosphate synthase 1.63 1.58
DYNLL2 dynein, light chain, LC8-type 2 1.6 2.52
CDT1 chromatin licensing and DNA replication factor 1 1.57 1.51
FAHD1 fumarylacetoacetate hydrolase domain containing 1 1.56 1.61
DOT1L DOT1-like, histone H3 methyltransferase (S. cerevisiae) 1.56 1.82
BTBD11 BTB (POZ) domain containing 11 1.55 1.71
FDR p-value <0.05.
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treatment groups based on p<0.05 and an additional five
were suggestive of significance (p < 0.10; Table 5). Tissue
levels of amino acids were consistently lower in fasted vs.
fed tissue, with statistically significant reductions in aspara-
gine and glutamine (p < 0.01). Presumably, these effects
were due to a change in the balance of protein synthesis/
proteolysis and to the catabolism of carbon skeletons for
energy in response to energy restriction, which is con-
sistent with up-regulated expression of genes involved
in amino acid catabolism (Figure 3). They may also re-
flect a decrease in plasma amino acid supply as
suggested by the decrease in total plasma amino acid
levels (evaluated by the content in total α-NH2-non-
protein nitrogen (αNH2NPN), i.e., mostly total amino
acids), as compared to fed controls [18]. In contrast to
fasting, tissue amino acid levels tended to be increased
in insulin-neutralized vs. fed, although only glutamine
showed a statistically significant response. Comparison
of insulin-neutralized vs. fasted chickens highlights the
divergent effects of treatments on amino acids (Figure 4).
Alanine, arginine, asparagine, glutamine, histidine, proline,
serine, threonine and tyrosine levels were all significantly
higher in insulin-neutralized vs. fasted, with differences
ranging from 1.7- to 3.4-fold. Two metabolites related to
glucose metabolism, D-glucono-1,5-lactone-6-phosphate
and glycerol-3-phosphate, were lower in both fasted and
insulin-neutralized treatments vs. fed, with the latter com-
parison nearing statistical significance (p< 0.1). D-glu-
cono-1,5-lactone-6-phosphate is a product of glucose-6-
phosphate dehydrogenase (G6PDH), an enzyme that, in
mammals is insulin-sensitive and rate-limiting for pentose
phosphate pathway activity and production of cellular
NADPH, an important cofactor for lipid metabolism [28].
However, pentose phosphate pathway activity is intrinsic-
ally low in chicken and is not stimulated when lipogenesis
is high; the production of cellular NADPH is more closely
related to malic enzyme activity [29]. Glycerol-3-
phosphate is a product of both glucose and pyruvate me-
tabolism and is used in triacylglycerol synthesis. Lower
levels with both treatments may reflect glycerol demand
for fatty acid reesterification in light of the apparent in-
crease in lipolysis in both treatment groups [18].
Correlated patterns of gene expression and metabolite
abundance were extracted using hierarchical clustering
to interconnect treatment effects on transcripts and
metabolites. Clusters 2 and 3 contained genes and meta-
bolites with lower abundance in fasted vs. fed or insulin
Table 4 Unique effects of insulin neutralization on differential gene expression









GCG Glucagon 2.91 LOC425670 glucagon receptor precursor 2.77
TCP11L2 t-complex 11 (mouse)-like 2 2.08 BAK1 BCL2-antagonist/killer 1 1.83
LOC416916 hypothetical LOC416916 1.98 CCT3 chaperonin containing TCP1, subunit 3 (gamma) 1.62
MAGI1 membrane associated guanylate kinase,
WW and PDZ domain containing 1
1.84 SETD7 SET domain containing (lysine methyltransferase) 7 1.62
SEPT10 septin 10 1.79 ST13 suppression of tumorigenicity 13 (colon carcinoma)
(Hsp70 interacting protein)
1.62
LSM14A LSM14A, SCD6 homolog A (S. cerevisiae); similar
to LSM14 homolog A (SCD6, S. cerevisiae)
1.71 AHSA1 AHA1, activator of heat shock 90 kDa protein
ATPase homolog 1 (yeast)
1.62
TOE1 target of EGR1, member 1 (nuclear) 1.59
AZIN1 antizyme inhibitor 1 1.56
FDR p-value <0.05.
Table 5 Fold change of fasting and insulin neutralization







adenosine 0.57 1.21 2.12*
alanine 0.66 1.57 2.38***
arginine 0.75 1.34 1.78**
asparagine 0.47*** 1.00 2.15***
D-glucono-1,5-lactone-6-phosphate 0.86 0.75* 0.87
glutamine 0.48*** 1.64* 3.43****
glycerol-3-phosphate 0.82 0.72* 0.87
histidine 0.64 1.38 2.17***
hypoxanthine 1.31 0.80 0.61**
N-acetyl-glutamate 0.64 1.34 2.09*
N-acetyl-L-serine 0.23** 1.70 7.30***
ornithine 0.77 1.59 2.05*
proline 0.63 1.50 2.39***
serine 0.67 1.61 2.39***
threonine 0.77 1.38 1.80**
tyrosine 0.74 1.30 1.76**
a hexose-phosphate 1.05 1.32** 1.26*
* p < 0.10, ** p < 0.05, *** p < 0.01, **** p < 0.001.
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neutralized tissue. The two clusters differed with respect
to the insulin neutralized group: cluster 3 contained ana-
lytes at intermediate levels between fasted and fed, while
cluster 2 contained those at levels comparable to or
greater than fed. Twelve of the 17 metabolites with sta-
tistically suggestive or significant effects of treatment, in-
cluding all of the amino acids and amino acid derivatives
(Additional file 4), were present in cluster 2 along with a
set of genes that included the p85α regulatory subunit of
PI3 kinase (PIK3R1), as well as ME, malonyl CoA de-
carboxylase and ELOVL6. Cluster 3 contained several
metabolites including both NAD+ and NADPH and was
significantly enriched in GO annotations related to
carbohydrate metabolism and in the KEGG pathways
TCA cycle, glycolysis/gluconeogenesis, pyruvate metabol-
ism and steroid biosynthesis (p < 0.05; Additional file 4).
Clusters 7 and 8 consisted of genes and metabolites with
higher levels in fasted than in the other two treatment
groups. These clusters were significantly enriched in GO
categories PPAR signaling and negative regulation of cellu-
lar biosynthesis and also contained citrate and pyruvate
(p< 0.05; Additional file 4).
Discussion
Despite roles as both a domestic food animal of worldwide
economic importance and a widely used model organism
with relevance for human obesity and insulin resistance,
few studies have examined regulation of gene expression
in chicken adipose tissue. To our knowledge, no studies of
nutritional regulation of chicken adipose tissue at the gen-
omic level have been reported in the published literature.
Likewise, although insulin is the most well-defined hormo-
nal mediator of metabolism in mammalian adipose tissue,
its role in chicken remains to be clarified. Therefore the
current study addressed two objectives: 1) characterize the
transcriptomic and metabolomic response to energy ma-
nipulation as a step toward enhanced understanding of
adipose biology in chicken; and 2) identify the effects of
insulin on chicken adipose tissue by including a group of
birds in which insulin action was blocked by immunoneu-
tralization with an anti-insulin antibody. We sought to
both identify potential new targets for genetic selection or
management strategies to reduce fat accumulation in
commercial broilers and to further develop chicken as a
model organism for studies of human obesity.
Although intrinsic lipogenic activity is low in chicken adi-
pose tissue, genes involved in fatty acid synthesis and stor-
age were suppressed and those in fatty acid mobilization
and oxidation were up-regulated by fasting. The 40 down-
regulated genes with fold changes greater than three were
significantly enriched for the GO annotation lipid biosyn-
thetic process (FDR <0.05), including genes that control
triglyceride synthesis (DGAT2 and AGPAT9) and fatty acid
synthesis (ACACA, ACLY and ME), elongation (ELOVL6),
and desaturation (FADS1). AGPAT9 and DGAT2 catalyze
the initial and final steps, respectively, of de novo triglycer-
ide synthesis. ACLY is the main enzyme for synthesis of
cytosolic acetyl-CoA, which is carboxylated to malonyl-
CoA by ACACA, the rate-limiting step in fatty acid synthe-
sis. Reducing equivalents for the conversion of malonyl-
CoA to palmitate are supplied by malic enzyme (ME).
ELOVL6 catalyzes elongation of palmitate to stearate and
appears to play a key role in insulin sensitivity [30,31].
Finally, FADS1 is rate-limiting for polyunsaturated fatty
acids (PUFA) biosynthesis and was recently implicated in
control of fasting glucose homeostasis in humans [32].
Genes altered by fasting in adipose tissue in this study over-
lapped with those shown to be differentially expressed in
chicken liver after 16 or 48 hours of fasting, including
ACLY, ACOX1, BCAT1 and PDK4 [33]. These authors
used a different array platform than ours, which precludes
precise quantitative comparisons. However, among the
genes changed in both studies, the fold changes observed in
adipose tissue were consistently greater than those in liver,
despite the longer duration of fasting in that study. For ex-
ample, PDK4 expression was up-regulated~18-fold by a
five hour fast in adipose tissue, but only~1.5-fold after a
16 hour fast in liver. While differences in sensitivity
Figure 3 KEGG pathway analysis of genes differentially expressed in fasting vs. fed. Genes differentially expressed in fasting vs. fed were
matched to KEGG pathway membership using ClueGO. The percentage and #genes/term indicates the percentage and number of the genes in
the pathway that are contained in the set of genes altered by fasting. • p< 0.1 * p < 0.05 **, p < 0.01, based on Benjamini-corrected p-value.
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Figure 4 Heat map of metabolites. The median value of each metabolite in each treatment group was used to calculate fold-change of fasted
vs. fed, insulin-neutralized (insneut) vs. fed, and insulin-neutralized vs. fasted, and then values were subjected to hierarchical clustering.
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between the two array platforms must be kept in mind,
these data suggest that adipose tissue metabolism in
chicken is at least as sensitive to energy status as hepatic
metabolism. Our results indicate that both fatty acid syn-
thesis and storage are dynamically regulated by energy sta-
tus in chicken adipose tissue, despite its modest (~ 15%)
contribution to the amount of stored fatty acids.
Both fasted and insulin-neutralized birds exhibited sig-
nificant increases in plasma glucagon. Parallel elevations in
plasma NEFA suggested that this resulted in significant lip-
olysis of stored triacylglycerol in both treatment groups.
During fasting, a considerable percentage of the liberated
fatty acids are re-esterified in adipocytes, and only a small
fraction traditionally have been thought to be oxidized in
the mitochondria of adipocytes through beta oxidation
[34]. However, recent studies in mice and in human adi-
pose tissue demonstrate that in some conditions fatty acid
oxidation in white adipose tissue is considerable and may
be an important determinant of obesity [35-37]. Consistent
with this concept, we found significant increases in a num-
ber of key enzymes that mediate mobilization of fatty acids
and their oxidation, including the rate-limiting enzymes in
both mitochondrial and peroxisomal fatty acid oxidation
(CPT1A and ACOX1, respectively). We measured tissue
levels of beta-hydroxybutyrate, a ketone product of beta
oxidation, to confirm that changes in gene expression had
functional consequences and found them to be signifi-
cantly elevated in adipose tissue of fasted vs. fed chickens.
Levels were numerically but not statistically higher in
insulin-neutralized adipose tissue (data not shown).
Qualitatively, fasting-induced changes in gene expression
resemble those induced by the fibrate class of drugs,
which activate PPARα and promote fatty acid oxidation in
white adipose tissue and are used clinically to treat hyper-
lipidemia [35,37-40]. These data suggest that dietary acti-
vation of PPARα, for example through supplementation
with fatty acids that preferentially bind and activate this
member of the PPAR family [41], may be a means to at-
tenuate fat deposition in commercial broilers. Such action
may underlie the reduced abdominal fat mass reported in
broilers that were fed diets rich in n-3 PUFA [42].
Both fasting and insulin neutralization elicited marked
upregulation of PDK4. PDK4 is a nutrient sensing fuel
switch that phosphorylates and inactivates pyruvate de-
hydrogenase, which shifts fuel use from glucose to fatty
acids and spares glucose for the brain during periods of
fasting [23,43-45]. PDK4 also enhances glycerol synthesis
in white adipose tissue by shunting pyruvate into glycero-
neogenesis, at least in the fed state [46]. Hepatic and skel-
etal muscle expression of PDK4 is increased by fatty acids,
acetyl CoA, NADH and the diabetic state and decreased
by insulin and pyruvate (rev. in [23,47]). Little is known
about PDK4 in chicken, but a recent study suggests it acts
as a glycogen sensor in muscle and thus plays comparable
roles to those in mammals [48]. In mouse white adipose
tissue, PDK4 expression was shown to be induced by acti-
vation of p38MAPK [49], which we found to be signifi-
cantly up-regulated with fasting and, to a lesser extent,
with insulin neutralization [19]. Although PDK4 was up-
regulated in both treatment groups, and both groups
showed evidence of increased lipolysis [18], only fasted
chickens presented a gene expression signature and tissue
beta-hydroxybutyrate levels that were clearly indicative of
fatty acid oxidation. Although we did not measure
malonyl-CoA levels, we predict that they were reduced
with fasting, but not insulin neutralization, based on
reduced expression of ACACA. Malonyl-CoA allosteri-
cally binds and inhibits CPT1A, minimizing fatty acid
transport and subsequent oxidation in mitochondria [50].
With insulin neutralization, increased PDK4 may thus be
more aligned with the demand for glycerol needed to re-
esterify fatty acids liberated by lipolysis [46]. Additional
experiments are needed to confirm that manipulation of
PDK4 alters fatty acid oxidation in chicken adipose tissue
and to delineate its relative contributions to fatty acid oxi-
dation and glyceroneogenesis under varying metabolic
states. If manipulation of PDK4 does alter fatty acid oxida-
tion, our results highlight this pathway as a potential tar-
get for reducing fatness, which has relevance for both
poultry and humans.
Microarray data indicate that the effects of fasting in
chicken adipose tissue extend beyond metabolism. GO
analysis highlighted pathways such as cell cycle and
cytokine-cytokine receptor interaction that are most
likely related to changes in the stromal vascular fraction,
which contains proliferating preadipocytes and cells of
the immune system. In particular, a number of genes
that regulate multiple steps in adipogenesis were signifi-
cantly altered by fasting. Chickens rapidly accumulate
abdominal fat after hatch, and until approximately
7 weeks of age this is due more to formation of new adi-
pocytes than to adipocyte hypertrophy [11]. Adipocytes
arise from mesenchymal stem cells in a two stage
process of lineage commitment to an adipocyte fate, fol-
lowed by differentiation of fibroblast-like preadipocytes
into mature fat-storing cells [51]. Members of both the
Wnt (MSC lineage commitment) and TGFβ/BMP (MSC
lineage commitment and preadipocyte competence) sig-
naling pathways were significantly regulated by fasting.
Fasting down-regulated expression of CEBPα and
PPARγ, two transcription factors that orchestrate the
cascade of gene expression changes that lead to terminal
adipocyte differentiation [51]. Expression of other adipo-
genic mediators including fibroblast growth factor 2
(FGF2), fibroblast growth factor receptor 1 (FGFR1)
[52], and nuclear receptor corepressor 1 (NCOR1) [53]
were also significantly regulated by fasting. Collectively,
these changes suggest that adipocyte number in
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chickens is dynamically tied to energy status, at least in
young chicks (such as those used herein) that are rap-
idly forming new adipocytes. An elegant study by Arner
et al. concluded that adipocyte number in humans is a
major determinant of adult fat mass and is determined
during early childhood [54]. Less is known about this
process in humans due to the limitations of sampling
adipose tissue, particularly during development and
from different abdominal depots. In light of what
appears to be sensitive regulation of adipogenesis by nu-
tritional state, chickens may thus be particularly valu-
able models in which to elucidate mechanisms of
adipocyte hyperplasia during development that would
inform the study of human obesity.
It is worth noting that, despite the uncertainty about
insulin signaling in chicken adipose tissue, fasting altered
the expression of several messengers encoding elements
of the insulin signaling cascade. Expression of PIK3CB,
which encodes the catalytic p110 subunit of PI3K, was
up-regulated with fasting, while PIK3R1, which encodes
the regulatory p85 subunit, was down-regulated. Such
regulation could maintain some insulin signals despite a
fall in plasma insulin level. CBLB and CRK, which medi-
ate insulin signals that are associated with lipid rafts
[55], were also up-regulated with fasting. In mammals,
this pathway stimulates glucose uptake independently of
PI3K activation, which may shed light on the apparent
refractoriness of PI3K activity to insulin that was
described in chicken skeletal muscle [18]. Therefore, the
potential effects of insulin on lipid storage and energy
utilization appear to be defended in the fasting state,
when insulin levels fall, by enhanced insulin sensitivity
at the post-receptor level. Additional studies are needed
to confirm this effect and to further explore the poten-
tial of PI3K-independent effects of insulin on glucose
utilization in chicken adipose tissue.
Insulin is not considered to be a key regulator of glu-
cose metabolism in chicken adipose tissue, although it
does induce glucose disposal in chicken liver and muscle
[14]. It is therefore not surprising that the majority of
genes significantly altered by both insulin neutralization
and fasting are not related to glucose metabolism and
lipid synthesis. The main exception is DGAT2, which
catalyzes the final step in esterification of fatty acids into
triglycerides. In fact, DGAT2 showed the most extreme
down-regulation (6.1- and 10.5-fold, insulin-neutralized
and fasted, respectively) in each treatment group, which
is surprising considering that other genes related to lipo-
genesis were only regulated by fasting. Suppression of
DGAT2 expression may be due to feedback by lipolysis,
which appeared to be increased in both treatment
groups based on plasma NEFA levels. In general, our
data indicate that insulin deprivation altered fatty acid
and glucose metabolism in a manner comparable to
fasting but to a lesser extent, such that most genes
involved in these pathways did not exhibit statistically
significant changes in expression. For example, cluster
analysis (Figure 2) revealed that some genes upregulated
by fasting were also increased by insulin neutralization
(clusters 1, 3 and 4); these three clusters were enriched
with genes in the KEGG pathways for fatty acid metab-
olism and PPAR signaling, including both ACOX1 and
CPT1A, among others. Similarly, among genes that were
downregulated by fasting, clustering discriminated a set
of genes (Figure 2, cluster 2) with a trend to also be
decreased (albeit to a lesser extent than in fasting) by in-
sulin deprivation. Interestingly, this cluster was signifi-
cantly enriched in functions related to carbohydrate
metabolism, suggesting that insulin does play some role
in chicken adipose glucose metabolism. Comparable
trends appeared in the metabolomic data. For example,
stearate and palmitate (the only fatty acids measured by
our MS platform) were lower (although not significantly)
in both fasted and insulin neutralized compared to fed
birds (Additional file 3). While the purpose of our study
design was to determine the specific effects of insulin on
chicken adipose tissue, we cannot exclude the possibility
that some of the overlapping changes in gene expression
were secondary to systemic factors, such as hypergluca-
gonemia present in both treatment groups [18]. In vitro
experiments using primary adipocytes or adipose
explants will be useful to confirm specific effects of insu-
lin on genes identified herein.
Of the 13 changes in expression that were unique to
insulin neutralization, the most interesting responses
were up-regulation of GCG, which encodes preprogluca-
gon (fold change = 2.91), and down-regulation of the glu-
cagon receptor (LOC425670, fold change =−2.77). The
proglucagon system in avians is more complex than in
mammals. The avian preproglucagon locus encodes two
distinct precursor proteins that yield different peptides
through alternative posttranslational processing: the
class A transcript (PGA) yields glucagon and glucagon-
like peptide-1 (GLP-1), while the class B transcript
(PGB) additionally produces glucagon-like peptide-2
(GLP-2) and is more like the mammalian transcript (rev.
in [56]). Adipose tissue expresses both transcripts, with
PGA being slightly more abundant, and is the third
highest preproglucagon expressing tissue in chicken, be-
hind pancreas and the proventriculus [57]. We used
transcript-specific QPCR to determine that only the PGB
transcript was up-regulated by insulin neutralization
(data not shown). Additional experiments are necessary
to delineate which of the encoded peptides are up-
regulated in parallel, but the coincident down-regulation
of the glucagon receptor suggests a paracrine glucagon
axis in chicken adipose tissue, and one that is regulated
by insulin. In support of this concept, plasma glucagon
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(presumably derived largely from pancreas) was elevated
comparably in both treatment groups [18], while GCG
expression in adipose tissue was only up-regulated by in-
sulin neutralization.
Tissue metabolomic analysis highlighted effects of in-
sulin neutralization that were divergent from fasting and
not readily apparent from microarray data. Most of the
tissue amino acids that were measured were higher with
insulin-neutralization but lower with fasting when each
group was compared to ad libitum fed controls. This
pattern parallels the levels of αNH2NPN levels in blood
[18]. Low levels in fasted adipose tissue were most likely
due to oxidation of the carbon skeletons for cellular en-
ergy through the tricarboxylic acid cycle (TCA) cycle
and/or for glyceroneogenesis, in the absence of dietary
glucose. Increased amino acid catabolism was reflected
in the differential expression profiles of the fasted vs. fed
comparison (Figure 3; Additional file 1). In the insulin
neutralized group, however, glucose supply from food
was maintained and preferentially oxidized for energy.
Elevated amino acids in the insulin neutralized group
may also reflect reduced utilization due to the lack of
insulin’s anabolic effects, particularly on the proliferating
cell population within adipose tissue. The metabolomics
approach used here measured only metabolite pool sizes
at the time that tissues were harvested, rather than the
effect of fasting or insulin neutralization on the rates of
metabolism through glycolysis and the TCA cycle. The
latter would be much more informative with respect to
the dynamic impact of treatment, but requires the use of
isotopic labeling (e.g., by feeding 13C-labelled glucose)
which was not performed in this study. Nonetheless, we
were able to demonstrate significant effects on some
metabolites that inform the parallel changes in gene ex-
pression, particularly in relation to amino acid metabol-
ism. Combined clustering of metabolomic and gene
expression together identified a set of genes correlated
with many amino acid levels, including PIK3R1, ME and
MCD.
Conclusions
In summary, we determined that adipose tissue metabol-
ism in the chicken is regulated by energy status and, to a
lesser extent by insulin. Although adipose tissue is not a
primary site of lipogenesis in chicken, the rate-limiting
genes for fatty acid synthesis were suppressed by fasting.
Likewise, fasting appeared to increase aspects of insulin
sensitivity based on expression profiles, despite the view
that chicken adipose tissue is relatively insensitive to insu-
lin. Consistent with this paradigm, insulin neutralization
significantly altered the expression of only a few genes
related to glucose and lipid metabolism. Nonetheless, a
considerable number of genes were altered by insulin
neutralization, many of which thus far have unclear roles
in adipose biology. Expression profiles suggest that even
short term fasting alters fat storage in broilers by enhan-
cing the oxidation of fatty acids. The initiating events that
trigger upregulation of the corresponding genes are un-
clear, but there is considerable evidence for activation of
PPARa, LXRa, and potentially other transcription factors
that are activated by fatty acid ligands. Further studies are
warranted to identify these triggers because of their poten-
tial impact on fat storage. Our data also suggest that
broiler chicks may be an informative model organism in
which to investigate dietary effects on adipose develop-
ment in light of what appears to be a relationship between
energy intake and adipogenesis. The results of this study
thus have dual benefit for both the poultry industry and
for studies of obesity in humans.
Methods
Animals
Male broiler chicks (ISA 915, Institut de Sélection Animale,
Saint Brieuc, France) from which samples were collected
for this study were hatched and raised under standard
conditions, as originally described by Dupont [18] and in
accordance with the guidelines for Care and Use of Agricul-
tural Animals in Agricultural Research and Teaching.
Briefly, at 16–17 days of age, chicks of similar body weights
were either allowed to continue feeding (ad libitum fed
controls), fasted for five hours, or fed but injected at 0, 2
and 4 hours with porcine anti-insulin serum (insulin neu-
tralized). Both the fed and fasted groups received injections
of normal porcine serum as a vehicle control. Abdominal
adipose tissue samples were harvested and rapidly snap-
frozen in liquid nitrogen, pulverized, then stored at -80°C
until analysis. Adipose samples from five birds in each
group were used for both microarray and metabolomic
analyses.
Gene expression
Total RNA was isolated from chicken adipose samples
using the RNeasy Lipid kit and incorporating an on-
column DNase treated with the RNase-free DNase Set
according to the manufacturer's protocol (Qiagen.com).
RNA quality and concentration were measured using the
Experion System (Bio-Rad.com); only RNA passing recom-
mended standards of quality was used for further studies.
Transcriptome profiling was performed by Genome
Quebec (Montreal, Canada) using the Affymetrix Gene-
Chip Chicken Genome Array (San Diego, CA). Microarray
data from this study are deposited in the Gene Expression
Omnibus (GEO) under the accession number GSE35581.
For real time RT-PCR validation, cDNA was synthesized
using the iScript cDNA Synthesis kit (Bio-Rad.com). Com-
mercially designed and validated primer sets (QuantiTect)
and the associated SYBR Green master mix (Qiagen.com)
were used to assay gene expression on a CFX96 real-time
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PCR detection system (Bio-Rad.com). All samples were
analyzed in triplicate and normalized to ß-tubulin. Relative
differences in gene expression were determined using the
2-ΔΔCT method and statistical differences were tested by
analysis of variance (ANOVA) [58].
Liquid chromatography coupled with tandem mass
spectrometry (LC-MS/MS)
Abdominal adipose tissue samples from five birds in
each treatment group (the same five birds used for ex-
pression profiling) were extracted by placing tissue in a
mortar containing liquid nitrogen and then powdering
with a pestle. Portions (8–40 mg) of the powered tissue
were weighed into 1.5 mL centrifuge tubes. Chilled
methanol (0.5 mL at −80°C) and internal standard (5 μL
of 1.7 mM benzoic acid in negative mode or 4.25 mM
tris(hydroxymethyl)aminomethane in positive mode)
were added to each tube. Each tube was mixed thor-
oughly by vortexing for two minutes, and the metabo-
lites were extracted from the tissue for 30 min at 4°C.
The tubes were then centrifuged (5 min, 4°C, 16.1 rcf )
and supernatant (210 μL) was split into two autosampler
vials. One of these samples was immediately placed on
the LC-MS/MS for analysis, while the other was stored
at −80°C for analysis in the opposite polarity ion mode
on the following day.
Samples were placed in an autosampler tray chilled to
4°C, and 10 μL of each was injected onto an LC column
for analysis. The chromatography method for positive
ion mode was reported previously by Bajad and cowor-
kers [59], with one exception that the column was
cooled to 10°C. The chromatography method for nega-
tive ion mode was performed as reported by Waters and
coworkers [60], except the gradient was allowed to run
50 min instead of 45 min to allow more thorough equili-
bration of the column. The eluent was introduced dir-
ectly into the MS via an electrospray ionization (ESI)
source fitted to a Finnigan TSQ Quantum Discovery
Max triple quadrupole MS (Thermo Electron, Waltham,
MA) through a 0.1 mm internal diameter fused silica ca-
pillary. The spray voltage was 4500 V in positive mode
or 3000 V in negative mode. The sheath gas (nitrogen)
was set to 40 psi, and the capillary temperature was set
to 290°C. The collision cell gas (argon) was set to a pres-
sure of 1.5 mTorr. Samples were analyzed using selected
reaction monitoring (SRM) mode with a scan width of
1m/z and a scan time of 0.05 s. The SRM parameters
for most metabolites have been published previously
[59]. This method was used to scan for almost 300 meta-
bolites. Xcalibur software (Thermo Scientific, Waltham,
MA) was used to manually assess the elution time of the
correct LC spectral peak for each metabolite-specific
SRM. The Quan Browser utility in Xcalibur was then
used to integrate the LC spectral peak area (in ion
counts) for each detected compound, and these data
were exported to a Microsoft Excel spreadsheet for fur-
ther processing.
Statistical analysis
Statistical analysis of the microarray data was performed
using R 2.9.0 and routines contained in Bioconductor (bio-
conductor.org). GC robust multi-array average (GCRMA)
was used to normalize and scale the raw data from CEL
files. The normalized data were filtered for low expression
by removing any probes with normalized expression less
than 3 in at least 5 arrays. Statistical significance of gene
expression differences were analyzed by one-way ANOVA
and empirical bayes using the limma package. Differential
expression was defined based on false discovery rate (FDR)
adjusted p-value <0.05. False discovery rate for differential
expression and for GO and KEGG enrichment testing was
controlled using the Benjamini-Hochberg method [61].
Venn diagrams of differentially expressed genes were plot-
ted to visualize the number of differentially expressed
genes for each treatment comparison and their intersec-
tions. Hierarchical clustering of significant genes was per-
formed using the hclust function and a hierarchical
clustering heatmap was created using heatmap.2 in the
gplots package. Hierarchical clustering also was used to
identify correlated patterns of gene expression and meta-
bolites. The Database for Annotation, Visualization and
Integrated Discovery (DAVID, version 6.7) and ClueGO, a
Cytoscape plug-in, were used for Gene Ontology (GO) at
level 6 and 7 and KEGG analysis of differentially expressed
genes [62,63]. Statistical analysis of metabolomic data was
performed using an analysis tool that we developed specif-
ically for metabolomic data analyses (Ernest et al., manu-
script in review). The script (metabR), written in the
language R, uses linear mixed-effect modeling to normalize
metabolomics data containing both fixed- and random-
effect confounding variables. The script averages any
replicate measurements (statistical sampling) made on ex-
perimental units and performs ANOVA to test for statis-
tical differences between experimental groups.
Additional files
Additional file 1: Differentially expressed genes for fasted vs. fed
chickens with fold change > |1.5|. Probe ID, gene symbol, gene title
and fold change are provided.
Additional file 2: Differentially expressed genes for insulin
neutralized vs. fed chickens. Probe ID, gene symbol, gene title and fold
change are provided.
Additional file 3: Metabolite levels across the three pairwise
comparisons of treatments. Metabolite, fold-change and p-value are
provided.
Additional file 4: Metabolite-gene clusters. Cluster, metabolite,gene
Ontology and KEGG annotation and benjamini corrected pvalue are
provided for clusters that contained both metabolites and genes.
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